CIBC Analysts On Valeant: Questions Still Unanswered After Investor Day
December 17, 2015 at 13:56 PM EST
Valeant Pharmaceuticals Intl Inc (NYSE: VRX) recently held its Investor Day, where management provided revised guidance, in line with ...